Introduction
In pharmaceutical operations, a refrigerator, freezer, vaccine carrier, temperature logger or backup generator is more than an asset on a fixed asset register. It can be critical to product quality, patient safety and business continuity.
This is especially important for medicines and vaccines that require controlled temperatures throughout storage and transportation. When organisations cannot reliably identify where cold-chain equipment is, whether it is functioning, who is responsible for it, or when it was last serviced, small recordkeeping weaknesses can become costly operational failures.
Poor pharmaceutical asset tracking can lead to expired medicines, damaged products, emergency equipment purchases, unnecessary maintenance costs and audit findings. In Ghana and other African markets, where power interruptions, long distribution routes and resource constraints can place additional pressure on cold-chain systems, the consequences can be even more significant.
The problem is therefore not simply that an organisation has a poor asset register. The real problem is losing visibility over the assets that protect the value and integrity of pharmaceutical inventory.
Why Asset Tracking Matters in the Pharmaceutical Cold Chain
The pharmaceutical cold chain covers the equipment, facilities, processes and transportation systems used to keep temperature-sensitive products within required conditions.
These may include:
- Cold rooms and refrigerators
- Freezers and ultra-low-temperature equipment
- Temperature monitoring devices
- Vaccine carriers and cold boxes
- Refrigerated vehicles
- Backup generators and power systems
- Solar-powered refrigeration systems
- Data loggers and monitoring equipment
Each asset has a role in maintaining product integrity. If a refrigerator fails, for example, the immediate concern is not only the cost of repairing the refrigerator. Products stored inside it may also become unusable.
This creates a direct connection between asset management, inventory management, financial control and pharmaceutical compliance.
An organisation that knows what it owns, where each asset is located, its condition, maintenance history and responsible custodian is better positioned to detect problems before they affect operations.
The Hidden Costs of Poor Pharmaceutical Asset Tracking
1. Product Losses From Equipment Failure
Cold-chain equipment does not usually fail at convenient times.
A refrigerator may stop working overnight. A generator may fail during a power outage. A temperature monitoring device may stop recording without staff noticing immediately.
If equipment records are incomplete, management may not know which assets are approaching the end of their useful lives or which ones have recurring faults.
The financial impact can extend beyond the equipment itself. Temperature-sensitive medicines and vaccines may have to be quarantined, tested or discarded.
For organisations operating with limited healthcare budgets, this represents money that could otherwise have supported patient care, additional stock or other essential programmes.
2. Higher Maintenance and Replacement Costs
Without accurate asset histories, maintenance often becomes reactive.
Instead of scheduling preventive maintenance based on equipment age, condition and usage, organisations respond after breakdowns occur. Emergency repairs are usually more disruptive and can cost more than planned maintenance.
Poor tracking can also result in duplicate purchases. A department may request another refrigerator because it believes existing capacity is insufficient, when the real issue is that an existing unit has been moved, poorly recorded or left unused at another location.
A reliable asset register helps management distinguish between capacity shortages and visibility problems.
3. Weak Accountability
An asset without a clear custodian can quickly become everyone’s responsibility and therefore no one’s responsibility.
Consider a cold-chain refrigerator transferred from a central warehouse to a regional facility. If the transfer is not documented properly, the original location may still show the refrigerator on its register while the receiving facility has no formal record of responsibility.
Over time, such gaps make it difficult to determine who should report damage, arrange maintenance or account for the asset during an audit.
Clear ownership and movement records strengthen accountability across warehouses, hospitals, pharmacies, distributors and field operations.
4. Compliance and Audit Risks
Pharmaceutical organisations operate in an environment where documentation matters.
Auditors and regulators may need evidence that equipment is appropriately maintained, monitored and controlled. A missing service record, incomplete asset register or unexplained equipment movement can raise questions about the reliability of operational controls.
Importantly, having an asset is not the same as being able to demonstrate control over that asset.
Good records provide an evidence trail showing what the organisation owns, where it is located, its condition, maintenance history, transfers and responsible personnel.
Why Ghanaian and African Operations Face Additional Pressure
Cold-chain management in emerging markets can involve challenges that make asset visibility particularly important.
Power reliability, dispersed healthcare facilities, long transportation routes, infrastructure limitations and varying technical capacity can increase the operational pressure on refrigeration systems.
For example, a facility may depend heavily on a generator or solar-powered refrigeration system as a backup. If that supporting asset is poorly tracked, management may discover its failure only when the primary power supply is interrupted.
Geographic dispersion also increases the importance of standardised records. A national health programme, NGO or pharmaceutical distributor managing assets across multiple regions cannot rely solely on informal knowledge held by individual employees.
The larger and more geographically dispersed the operation becomes, the greater the need for reliable asset information.
What Effective Cold-Chain Asset Tracking Should Capture
A useful pharmaceutical asset register should go beyond an asset name and purchase price.
At minimum, organisations should consider recording:
Asset Identification
- Unique asset number
- Equipment type and model
- Manufacturer and serial number
- Date acquired
- Purchase cost
Location and Responsibility
- Current location
- Department or facility
- Assigned custodian
- Transfer history
Condition and Maintenance
- Current operating condition
- Installation date
- Warranty information
- Maintenance schedule
- Service history
- Repair records
- Replacement or disposal status
Cold-Chain Information
Where relevant, records should also connect equipment to temperature monitoring requirements, calibration records and incidents involving temperature excursions.
This creates a much more useful picture of the asset’s operational value and risk.
From Asset Register to Asset Intelligence
The goal of asset tracking should not be to create another spreadsheet that nobody updates.
The real objective is to turn asset information into management information.
For example, management should be able to answer questions such as:
- Which refrigeration units are approaching replacement?
- Which facilities have repeated equipment failures?
- Which assets have not received scheduled maintenance?
- Where are critical backup power systems located?
- Which assets have changed locations without proper documentation?
- How much has been spent maintaining a particular equipment category?
- Which facilities have the highest cold-chain asset risk?
These questions help finance teams improve budgeting, operations teams improve reliability and executives make better investment decisions.
Practical Steps for Improving Pharmaceutical Asset Tracking
1. Conduct a Physical Asset Verification
Start by comparing the asset register with what actually exists.
Record each asset’s location, identification number, condition and custodian. Investigate assets that are missing, duplicated or recorded at the wrong location.
2. Assign Unique Asset Identifiers
Every critical asset should have a unique identification number. Where appropriate, barcode or QR-code systems can make verification and movement tracking faster.
3. Establish Movement Controls
Transfers between warehouses, facilities and departments should be documented. Responsibility should change formally when an asset changes location or custodian.
4. Link Maintenance to the Asset Record
Maintenance information should remain connected to the specific equipment involved. This allows organisations to identify recurring failures and calculate the true cost of maintaining older assets.
5. Introduce Periodic Physical Verification
Asset records should not be treated as permanent once created. Regular physical verification helps identify missing equipment, unauthorised movements, inaccurate locations and changes in condition.
6. Use Technology Where It Adds Value
Digital asset management systems can improve visibility across multiple locations, automate reminders and create audit trails. However, technology does not solve poor processes by itself.
If staff do not update records when equipment moves or undergoes maintenance, even sophisticated systems will eventually contain unreliable information.
The Financial Case for Better Asset Visibility
Good asset tracking is often viewed as an accounting requirement. In pharmaceutical operations, it is much broader than that.
Accurate records help finance teams forecast capital expenditure, identify underutilised assets and understand maintenance costs. Operations teams gain better visibility over equipment availability and reliability. Procurement teams can make better purchasing decisions. Senior management gains clearer information about operational risks.
Most importantly, the organisation can better protect the pharmaceutical inventory that depends on these assets.
A relatively small investment in stronger asset controls can therefore help prevent much larger costs associated with emergency repairs, unnecessary purchases, product wastage and operational disruption.
Conclusion
Cold-chain failures are rarely caused by one problem alone. Equipment condition, power supply, maintenance, staff practices, monitoring and recordkeeping all contribute to the reliability of the system.
Poor asset tracking makes each of these risks harder to manage because decision-makers are operating without a dependable picture of what equipment exists, where it is, what condition it is in and whether it is being properly maintained.
For pharmaceutical companies, healthcare facilities, NGOs, government programmes and other organisations managing temperature-sensitive products, asset visibility is an operational control not merely an accounting exercise.
When organisations treat asset records as living management information rather than static paperwork, they can make better maintenance decisions, strengthen accountability, reduce avoidable losses and build a more resilient cold chain.